Commission Recommendation of 11 April 2006 on risk reduction measures for the substances: Dibutylphthalate; 3,4-Dichloroaniline; Di- isodecyl phthalate; 1,2-Benzenedicarboxylic acid, di-C 9-11 -branched alkyl esters, C 10 -rich; Di- isononyl phthalate; 1,2-Benzenedicarboxylic acid, di-C 8-10 -branched alkyl esters, C 9 -rich; Ethylenediaminetetraacetate; Methyl acetate; Monochloroacetic acid; n-Pentane; Tetrasodium ethylenediaminetetraacetate
委员会2006年4月11日关于以下物质的风险降低措施的建议:邻苯二甲酸二丁酯；3,4-二氯苯胺；邻苯二甲酸二异癸酯；1,2-苯二甲酸 二-C 9-11-支链烷基酯 富含C 10；邻苯二甲酸二异壬酯；1,2-苯二甲酸 二-C 8-10-支链烷基酯 富含C 9；乙二胺四乙酸；乙酸甲酯；一氯乙酸；正戊烷；乙二胺四乙酸四钠（Te
2006-04-11
EU 841-2017
Commission Implementing Regulation (EU) 2017/841 of 17 May 2017 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, Ampelomyces quisqualis strain: aq 10, benalaxyl, bentazone, bifenazate, bromoxynil, carfentrazone ethyl, chlorpropham, cyazofamid, desmedipham, diquat, DPX KE 459 (flupyrsulfuron-methyl), etoxazole, famoxadone, fenamidone, flumioxazine, foram
2017年5月17日委员会实施条例（EU）2017/841修订了第540/2011号实施条例（EU） 涉及延长活性物质α-氯氰菊酯、蛇葡萄球菌quisqualis菌株:aq 10、苯甲氧基、苯达松、联苯氮酯、溴苯腈、卡芬太宗乙基、氯丙嗪、环唑法姆、地塞米松、敌草胺、DPX KE 459（甲基氟吡嘧磺隆）的批准期 依托恶唑、法莫沙酮、芬胺酮、氟米沙嗪、福拉姆